IκBβ-mediated NF-κB activation confers protection against hyperoxic lung injury

American Journal of Respiratory Cell and Molecular Biology

Volumn 50, Issue 2, 2014, Pages 429-438

  Michaelis, Katherine A ^a   Agboke, Fadeke ^b   Liu, Thanh ^a   Han, Kristie ^a   Muthu, Manasa ^b   Galambos, Csaba ^a   Yang, Guang ^b   Dennery, Phyllis A ^b,c   Wright, Clyde J ^a  

^a University of Colorado Denver and Children s Hospital Colorado   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

NF B; IkB; hyperoxic lung injury; apoptosis; Inflammation

Indexed keywords

COMPLEMENTARY DNA; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 11; INTERLEUKIN 1BETA; INTERLEUKIN 6; OXYGEN; PROTEIN BCL 2; PROTEIN BCL XL;

ADULT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM; EPITHELIUM; EXPOSURE; HYPEROXIA; LEUKOCYTE; LONG TERM EXPOSURE; LUNG INJURY; LUNG LAVAGE; MORTALITY; MOUSE; NONHUMAN; PROMOTER REGION; PROTECTION; PROTEIN CONTENT; PROTEIN EXPRESSION; SURVIVAL; UPREGULATION; WILD TYPE;

ANIMALS; APOPTOSIS; CYTOKINES; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; HYPEROXIA; I-KAPPA B PROTEINS; LUNG; LUNG INJURY; MICE; MICE, INBRED ICR; NF-KAPPA B; SIGNAL TRANSDUCTION;

EID: 84893266530     PISSN: 10441549     EISSN: 15354989     Source Type: Journal    
DOI: 10.1165/rcmb.2013-0303OC     Document Type: Article

References (49)

1. Smith JL. The pathological effects due to increase of oxygen tension in the air breathed. J Physiol 1899;24:19-35.
2. Matute-Bello G, Frevert CW, Martin TR. Animal models of acute lung injury. Am J Physiol Lung Cell Mol Physiol 2008;295:L379-L399.
3. Johnston CJ, Wright TW, Reed CK, Finkelstein JN. Comparison of adult and newborn pulmonary cytokine mRNA expression after hyperoxia. Exp Lung Res 1997;23:537-552.
4. Crapo JD. Morphologic changes in pulmonary oxygen toxicity. Annu Rev Physiol 1986;48:721-731.
5. TsanMF, White JE, Michelsen PB, Wong GH. Pulmonary O2 toxicity: role of endogenous tumor necrosis factor. Exp Lung Res 1995;21:589-597.
6. Raj JU, Hazinski TA, Bland RD. Oxygen-induced lung microvascular injury in neutropenic rabbits and lambs. J Appl Physiol 1985;58: 921-927.
7. Guthmann F, Wissel H, Rustow B. Early subcutaneous administration of etanercept (enbrel) prevents from hyperoxia-induced lung injury. Exp Lung Res 2009;35:770-780.
8. Husari AW, Khayat A, Awdeh H, Hatoum H, Nasser M, Mroueh SM, Zaatari G, El-Sabban M, Dbaibo GS. Activated protein C attenuates acute lung injury and apoptosis in a hyperoxic animal model. Shock 2010;33:467-472.
9. Yamada M, Kubo H, Kobayashi S, Ishizawa K, Sasaki H. Interferongamma: a key contributor to hyperoxia-induced lung injury in mice. Am J Physiol Lung Cell Mol Physiol 2004;287:L1042-L1047.
10. Waxman AB, Kolliputi N. IL-6 protects against hyperoxia-induced mitochondrial damage via BCL-2-induced BAK interactions with mitofusins. Am J Respir Cell Mol Biol 2009;41:385-396.
11. He CH, Waxman AB, Lee CG, Link H, Rabach ME, Ma B, Chen Q, Zhu Z, Zhong M, Nakayama K, et al. BCL-2-related protein A1 is an endogenous and cytokine-stimulated mediator of cytoprotection in hyperoxic acute lung injury. J Clin Invest 2005; 115:1039-1048.
12. Waxman AB, Einarsson O, Seres T, Knickelbein RG, Warshaw JB, Johnston R, Homer RJ, Elias JA. Targeted lung expression of interleukin-11 enhances murine tolerance of 100% oxygen and diminishes hyperoxia-induced DNA fragmentation. J Clin Invest 1998;101:1970-1982.
13. Gore A, Muralidhar M, Espey MG, Degenhardt K, Mantell LL. Hyperoxia sensing: from molecular mechanisms to significance in disease. J Immunotoxicol 2010;7:239-254.
14. Qureshi ST, Zhang X, Aberg E, Bousette N, Giaid A, Shan P, Medzhitov RM, Lee PJ. Inducible activation of TLR4 confers resistance to hyperoxia-induced pulmonary apoptosis. J Immunol 2006;176: 4950-4958.
15. Yang G, Abate A, George AG, Weng YH, Dennery PA. Maturational differences in lung NF-kappaB activation and their role in tolerance to hyperoxia. J Clin Invest 2004;114:669-678.
16. Lu X, Liu H, Wang L, Schaefer S. Activation of NF-kappaB is a critical element in the antiapoptotic effect of anesthetic preconditioning. Am J Physiol Heart Circ Physiol 2009;296:H1296-H1304.
17. Tahepold P, Vaage J, Starkopf J, Valen G. Hyperoxia elicits myocardial protection through a nuclear factor kappaB-dependent mechanism in the rat heart. J Thorac Cardiovasc Surg 2003;125: 650-660.
18. Franek WR, Horowitz S, Stansberry L, Kazzaz JA, Koo HC, Li Y, Arita Y, Davis JM, Mantell AS, Scott W, et al. Hyperoxia inhibits oxidantinduced apoptosis in lung epithelial cells. J Biol Chem 2001;276: 569-575.
19. Chen LW, Egan L, Li ZW, Greten FR, Kagnoff MF, Karin M. The two faces of IKK and NF-kappaB inhibition: prevention of systemic inflammation but increased local injury following intestinal ischemia-reperfusion. Nat Med 2003;9:575-581.
20. Suzuki Y, Nishio K, Takeshita K, Takeuchi O, Watanabe K, Sato N, Naoki K, Kudo H, Aoki T, Yamaguchi K. Effect of steroid on hyperoxia-induced ICAM-1 expression in pulmonary endothelial cells. Am J Physiol Lung Cell Mol Physiol 2000;278:L245-L252.
21. Gilmore T. NF-κB target genes [internet]. Boston 9MA: Boston University; c2013 [accessed 2013 Oct 24]. Available from: http://www.bu.edu/nf- kb/gene-resources/target-genes//
22. Perkins ND. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol 2007;8:49-62.
23. Rao P, Hayden MS, Long M, Scott ML, West AP, Zhang D, Oeckinghaus A, Lynch C, Hoffmann A, Baltimore D, et al. Ikappabbeta acts to inhibit and activate gene expression during the inflammatory response. Nature 2010;466:1115-1119.
24. Huang TT, Miyamoto S. Postrepression activation of NF-kappaB requires the amino-terminal nuclear export signal specific to IkappaBalpha. Mol Cell Biol 2001;21:4737-4747.
25. Tam WF, Sen R. IkappaB family members function by different mechanisms. J Biol Chem 2001;276:7701-7704.
26. Suyang H, Phillips R, Douglas I, Ghosh S. Role of unphosphorylated, newly synthesized I kappa B beta in persistent activation of NFkappa B. Mol Cell Biol 1996;16:5444-5449.
27. Hoffmann A, Levchenko A, Scott ML, Baltimore D. The IkappaB-NFkappaB signaling module: temporal control and selective gene activation. Science 2002;298:1241-1245.
28. Cheng JD, Ryseck RP, Attar RM, Dambach D, Bravo R. Functional redundancy of the nuclear factor kappa B inhibitors I kappa B alpha and I kappa B beta. J Exp Med 1998;188:1055-1062.
29. Liu Y, Mei J, Gonzales L, Yang G, Dai N, Wang P, Zhang P, Favara M, Malcolm KC, Guttentag S, et al. IL-17A and TNF-alpha exert synergistic effects on expression of CXCL5 by alveolar type II cells in vivo and in vitro. J Immunol 2011;186:3197-3205.
30. Yang G, Madan A, Dennery PA. Maturational differences in hyperoxic AP-1 activation in rat lung. Am J Physiol Lung Cell Mol Physiol 2000; 278:L393-L398.
31. Ward NS, Waxman AB, Homer RJ, Mantell LL, Einarsson O, Du Y, Elias JA. Interleukin-6-induced protection in hyperoxic acute lung injury. Am J Respir Cell Mol Biol 2000;22:535-542.
32. Barazzone C, Horowitz S, Donati YR, Rodriguez I, Piguet PF. Oxygen toxicity in mouse lung: pathways to cell death. Am J Respir Cell Mol Biol 1998;19:573-581.
33. Perkowski S, Sun J, Singhal S, Santiago J, Leikauf GD, Albelda SM. Gene expression profiling of the early pulmonary response to hyperoxia in mice. Am J Respir Cell Mol Biol 2003;28:682-696.
34. Iosef C, Alastalo TP, Hou Y, Chen C, Adams ES, Lyu SC, Cornfield DN, Alvira CM. Inhibiting NF-kappaB in the developing lung disrupts angiogenesis and alveolarization. Am J Physiol Lung Cell Mol Physiol 2012;302:L1023-L1036.
35. Corne J, Chupp G, Lee CG, Homer RJ, Zhu Z, Chen Q, Ma B, Du Y, Roux F, McArdle J, et al. IL-13 stimulates vascular endothelial cell growth factor and protects against hyperoxic acute lung injury. J Clin Invest 2000;106:783-791.
36. Ho YS, Vincent R, Dey MS, Slot JW, Crapo JD. Transgenic models for the study of lung antioxidant defense: enhanced manganese-containing superoxide dismutase activity gives partial protection to B6C3 hybrid mice exposed to hyperoxia. Am J Respir Cell Mol Biol 1998;18:538-547.
37. Wright CJ, Agboke F, Muthu M, Michaelis KA, Mundy MA, La P, Yang G, Dennery PA. Nuclear factor-kappaB (NF-kappaB) inhibitory protein IkappaBbeta determines apoptotic cell death following exposure to oxidative stress. J Biol Chem 2012;287:6230-6239.
38. Mantell LL, Kazzaz JA, Xu J, Palaia TA, Piedboeuf B, Hall S, Rhodes GC, Niu G, Fein AF, Horowitz S. Unscheduled apoptosis during acute inflammatory lung injury. Cell Death Differ 1997;4:600-607.
39. Pryhuber GS, O'Brien DP, Baggs R, Phipps R, Huyck H, Sanz I, Nahm MH. Ablation of tumor necrosis factor receptor type I (p55) alters oxygen-induced lung injury. Am J Physiol Lung Cell Mol Physiol 2000;278:L1082-L1090.
40. Staversky RJ, Vitiello PF, Yee M, Callahan LM, Dean DA, O'Reilly MA. Epithelial ablation of BCL-XL increases sensitivity to oxygen without disrupting lung development. Am J Respir Cell Mol Biol 2010;43:376-385.
41. Otterbein LE, Kolls JK, Mantell LL, Cook JL, Alam J, Choi AM. Exogenous administration of heme oxygenase-1 by gene transfer provides protection against hyperoxia-induced lung injury. J Clin Invest 1999;103:1047-1054.
42. O'Reilly MA, Staversky RJ, Watkins RH, Reed CK, de Mesy Jensen KL, Finkelstein JN, Keng PC. The cyclin-dependent kinase inhibitor p21 protects the lung from oxidative stress. Am J Respir Cell Mol Biol 2001;24:703-710.
43. Wu YC, O'Reilly MA. BCL-X(L) is the primary mediator of p21 protection against hyperoxia-induced cell death. Exp Lung Res 2011;37:82-91.
44. Zhang X, Shan P, Qureshi S, Homer R, Medzhitov R, Noble PW, Lee PJ. Cutting edge: TLR4 deficiency confers susceptibility to lethal oxidant lung injury. J Immunol 2005;175:4834-4838.
45. Lu Y, Parkyn L, Otterbein LE, Kureishi Y, Walsh K, Ray A, Ray P. Activated Akt protects the lung from oxidant-induced injury and delays death of mice. J Exp Med 2001;193:545-549.
46. Budinger GR, Mutlu GM, Urich D, Soberanes S, Buccellato LJ, Hawkins K, Chiarella SE, Radigan KA, Eisenbart J, Agrawal H, et al. Epithelial cell death is an important contributor to oxidant-mediated acute lung injury. Am J Respir Crit Care Med 2011;183:1043-1054.
47. Sue RD, Belperio JA, Burdick MD, Murray LA, Xue YY, Dy MC, Kwon JJ, Keane MP, Strieter RM. CXCR2 is critical to hyperoxia-induced lung injury. J Immunol 2004;172:3860-3868.
48. Adawi A, Zhang Y, Baggs R, Finkelstein J, Phipps RP. Disruption of the CD40-CD40 ligand system prevents an oxygen-induced respiratory distress syndrome. Am J Pathol 1998;152:651-657.
49. Sun SC, Ganchi PA, Ballard DW, Greene WC. NF-kappa B controls expression of inhibitor I kappa B alpha: evidence for an inducible autoregulatory pathway. Science 1993;259:1912-1915.